Aurinia Pharmaceuticals Files Proxy Materials
Ticker: AUPH · Form: DEFA14A · Filed: Apr 30, 2025 · CIK: 1600620
| Field | Detail |
|---|---|
| Company | Aurinia Pharmaceuticals Inc. (AUPH) |
| Form Type | DEFA14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance, sec-filing
TL;DR
Aurinia Pharma filed proxy docs, no fee. Standard corporate stuff.
AI Summary
Aurinia Pharmaceuticals Inc. filed a Definitive Additional Materials proxy statement (DEFA14A) on April 30, 2025. This filing is related to the company's proxy materials and does not involve a fee. The company is based in Edmonton, Alberta, Canada, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing indicates that Aurinia Pharmaceuticals is proceeding with its corporate governance and shareholder communication processes, which are essential for the ongoing operations and strategic decisions of a publicly traded company.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement, indicating standard corporate governance procedures rather than a specific event with immediate financial risk.
Key Players & Entities
- Aurinia Pharmaceuticals Inc. (company) — Registrant
- Glass Lewis (company) — Proxy statement preparer
- United States Securities and Exchange Commission (company) — Regulatory body
FAQ
What is the purpose of this DEFA14A filing?
This filing is a Definitive Additional Materials proxy statement, indicating it contains supplementary information for shareholders related to a meeting or vote.
When was this filing submitted?
The filing was submitted on April 30, 2025.
Is there a filing fee associated with this document?
No, the filing explicitly states 'No fee required.'
Where is Aurinia Pharmaceuticals Inc. headquartered?
Aurinia Pharmaceuticals Inc. is headquartered in Edmonton, Alberta, Canada, with a business address at #140, 14315 - 118 Avenue, Edmonton, A0, T5L 4S6.
What is Aurinia Pharmaceuticals Inc.'s Standard Industrial Classification (SIC) code?
Aurinia Pharmaceuticals Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 30, 2025 regarding Aurinia Pharmaceuticals Inc. (AUPH).